PARIS 2024
Updates will be added to this page starting August 2024.
Autism Spectrum Disorder (ASD) is one of the fastest-growing developmental disorders in the country. Because there is so much controversy surrounding the primary cause, diagnosis, and appropriate treatments, little progress has been made in understanding the best course of action for families affected by ASD.
The goal for 2024 is to prove that the NVLife Program is a simple, effective method to alleviate the debilitating symptoms associated with autism.
Our previous NVLife participants have shown significant improvements in eye contact, communication, social interaction, attention and behaviors for each of the children with ASD.
2024 GOAL
To demonstrate the efficacy and replicability of NVLife to address the symptoms associated with ASD.
Provide the data necessary to further help alleviate the suffering from symptoms associated with ASD.
Bring awareness and educate the public on the profound effects of NVLife.
donate
Your donation to the Neurovascular Foundation makes a difference. Contribution help provide free services for those in need.